Oxycodone Hcl Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
See Also
How Supplied
Contact supplier
Manufacturer
Mechanism of Action
Oxycodone Hcl Indications
Indications
Limitations of Use
Due to risks of addiction, abuse, and misuse with opioids (can occur at any dosage or duration), reserve for use in patients for whom alternative treatment options (eg, non-opioid analgesics, opioid combination products) are not tolerated or inadequate to provide analgesia. Should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.
Oxycodone Hcl Dosage and Administration
Adult
Children
Oxycodone Hcl Contraindications
Contraindications
Oxycodone Hcl Boxed Warnings
Boxed Warning
Serious and life-threatening risks from use of Oxycodone Hydrochloride: Addiction, abuse, and misuse; Life-threatening respiratory depression; Accidental ingestion; Risks from concomitant use with benzodiazepines or other CNS depressants; Neonatal opioid withdrawal syndrome; Opioid analgesic risk evaluation and mitigation strategy (REMS); Cytochrome P450 3A4 interaction; For oral solution: Risk of medication errors.
Oxycodone Hcl Warnings/Precautions
Warnings/Precautions
Assess the potential need for access to naloxone when initiating and renewing therapy. Consider prescribing naloxone based on risk factors for overdose (eg, history of opioid use disorder, prior opioid overdose, household members or other close contacts at risk for accidental ingestion or overdose). Abuse potential (monitor). Life-threatening respiratory depression esp. during initiation or following dose increases. Accidental exposure may cause fatal overdose (esp. in children). Sleep-related breathing disorders (including central sleep apnea (CSA), sleep-related hypoxemia); consider dose reduction if CSA develops. Opioid-induced hyperalgesia (OIH) and allodynia; consider decreasing dose of current opioid or opioid rotation if OIH is suspected. COPD, cor pulmonale, decreased respiratory reserve, hypoxia, hypercapnia, or pre-existing respiratory depression; monitor and consider non-opioid analgesics. Adrenal insufficiency. Monitor for signs of hypotension when initiating or titrating dose. Head injury. Increased intracranial pressure, brain tumors; monitor. Seizure disorders. CNS depression. Impaired consciousness, coma, shock; avoid. Biliary tract disease. Acute pancreatitis. Drug abusers. Renal or hepatic impairment. Reevaluate periodically. Avoid abrupt cessation. Elderly. Cachectic. Debilitated. Pregnancy; potential neonatal opioid withdrawal syndrome during prolonged use. Labor & delivery: not recommended. Nursing mothers: monitor infants.
REMS
Oxycodone Hcl Pharmacokinetics
Absorption
Approximately 60–87% of an oral dose reaches the systemic circulation compared with a parenteral dose.
Distribution
Volume of distribution: 2.6 L/kg (after IV admin). Plasma protein bound: ~45%.
Elimination
Renal. Half-life: ~4 hours. Total plasma clearance: 0.8 L/min.
Oxycodone Hcl Interactions
Interactions
Oxycodone Hcl Adverse Reactions
Adverse Reactions
Nausea, constipation, vomiting, headache, pruritus, insomnia, dizziness, asthenia, somnolence; respiratory depression, orthostatic hypotension, syncope, OIH and allodynia.
Oxycodone Hcl Clinical Trials
See Literature
Oxycodone Hcl Note
Notes
Oxycodone Hcl Patient Counseling
See Literature